Deep Brain Stimulation (DBS) for Advanced Parkinson’s Disease: The Window for Intervention

OPD

MON - Sat: 11:00 AM - 4:00 PM

Deep Brain Stimulation (DBS) for Advanced Parkinson’s Disease: The Window for Intervention

In the early stages of Parkinson’s disease, dopaminergic medications (like Levodopa) serve as highly effective chemical replacements. However, as the disease progresses, patients frequently experience debilitating motor fluctuations—characterized by rapid "off-periods" of rigidity or medication-induced involuntary movements known as dyskinesia.

When pharmacological management reaches its ceiling of efficacy, Deep Brain Stimulation (DBS) emerges as a transformative functional neurosurgical intervention.

The Mechanics of Neuromodulation

DBS functions analogously to a cardiac pacemaker. Micro-electrodes are stereotactically implanted deep within specific basal ganglia structures (typically the Subthalamic Nucleus or Globus Pallidus). These electrodes connect to a subcutaneous pulse generator. Once activated, continuous electrical impulses override the erratic neurological signals responsible for tremors and bradykinesia.

Criteria for Optimal Candidacy

• Has lived with a confirmed Parkinson's diagnosis for at least 4 years.
•Retains a positive response to Levodopa but suffers from severe motor fluctuations.
• Presents without severe cognitive decline or irreversible dementia.

Clinical Takeaway

DBS is not a last-resort measure. Consulting a functional neurosurgeon as soon as medication fluctuations become unmanageable ensures intervention occurs within the optimal window, yielding the most robust restoration of motor control.

OPD

Call us

email us